Literature DB >> 2616030

Retinal dopamine sensitivity to MPP+ toxicity: electrophysiological and biochemical evaluation.

C Harnois1, G Marcotte, M Daigle, T Di Paolo.   

Abstract

This study concerns the effect of intravitreal injection of 1-methyl-4-phenylpyridinium ion (MPP+) on the electroretinograms (ERG) and on the levels of retinal dopamine (DA) in rabbits. The right eye was injected intravitreously with MPP+ while the other received only the vehicle and served as control. The administration of 7, 40, 70 or 700 micrograms MPP+ resulted in a dose-related decrease of the amplitude of the a and b-waves as well as the oscillatory potentials (OPs) of the ERG, down to extinction. In contrast, the retinal DA content was decreased only with the 700 micrograms MPP+ dose. Fluorescein angiography demonstrated abnormalities in the retinal circulation of all MPP+-treated eyes. These observations indicate that MPP+ causes lesions to the retinal vessels at doses non-toxic to the retinal dopaminergic neurons. These data suggest that intravitreal injection of MPP+ cannot be used to study the physiological role of retinal DA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2616030     DOI: 10.1016/0304-3940(89)90784-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

Review 1.  The pathology roadmap in Parkinson disease.

Authors:  D James Surmeier; David Sulzer
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

Review 2.  Neuronal vulnerability, pathogenesis, and Parkinson's disease.

Authors:  David Sulzer; D James Surmeier
Journal:  Mov Disord       Date:  2012-07-12       Impact factor: 10.338

3.  Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

Authors:  Kyoung-In Cho; Kelly Searle; Mason Webb; Haiqing Yi; Paulo A Ferreira
Journal:  Cell Mol Life Sci       Date:  2012-07-21       Impact factor: 9.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.